Advertisement
Canada markets open in 6 hours 37 minutes

  • S&P/TSX

    22,259.47
    +312.06 (+1.42%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • CAD/USD

    0.7308
    -0.0013 (-0.18%)
     

  • CRUDE OIL

    78.53
    +0.05 (+0.06%)
     

  • Bitcoin CAD

    87,082.56
    -888.06 (-1.01%)
     

  • CMC Crypto 200

    1,366.20
    +1.07 (+0.08%)
     

  • GOLD FUTURES

    2,328.70
    -2.50 (-0.11%)
     

  • RUSSELL 2000

    2,060.67
    +24.95 (+1.23%)
     

  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     

  • NASDAQ futures

    18,181.75
    -13.75 (-0.08%)
     

  • VOLATILITY

    13.49
    0.00 (0.00%)
     

  • FTSE

    8,213.49
    +41.34 (+0.51%)
     

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • CAD/EUR

    0.6788
    -0.0004 (-0.06%)
     

SHAREHOLDER ALERT - The Chemours Company (CC) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: December 9, 2019

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / October 18, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (CC) and certain of its officers, on behalf of shareholders who purchased Chemours securities between February 16, 2017 and August 1, 2019 (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/cc.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.

The Complaint alleges that, throughout the Class Period, Defendants misled investors by representing that Chemours had appropriately accounted and accrued reserves for its environmental liabilities, that the possibility of costs exceeding accrued amounts was "remote," and that, in any event, additional costs would not be material. The complaint continues to allege that Chemours also assured investors that its "policies, standards and procedures are properly designed to prevent unreasonable risk of harm to people and the environment," and that its "handling, manufacture, use and disposal of hazardous substances are in accordance with applicable environmental laws and regulations." Consequently, the Company's shares traded at artificially inflated prices throughout the Class Period.

If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/cc or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Chemours you have until December 9, 2019 to request that the Court appoint you as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

ADVERTISEMENT

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/562751/SHAREHOLDER-ALERT--The-Chemours-Company-CC--Bronstein-Gewirtz-Grossman-LLC-Notifies-Investors-of-Class-Action-and-Lead-Plaintiff-Deadline-December-9-2019